MicroTech Medical, Inc. — a Chinese maker of medical equipment for the diagnosis and treatment of diabetes — has raised 575 million yuan ($88 million) in a funding round led by Beijing Taikang Investment Management, the investment arm of TaiKang Life’s subsidiary Taikang Asset Management.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
